Literature DB >> 30987429

Setting clinical performance specifications to develop and evaluate biomarkers for clinical use.

Sarah J Lord1,2, Andrew St John3, Patrick Mm Bossuyt4, Sverre Sandberg5,6,7, Phillip J Monaghan8, Maurice O'Kane9, Christa M Cobbaert10, Ralf Röddiger9,11, Lieselotte Lennartz12, Cecilia Gelfi13, Andrea R Horvath14,15.   

Abstract

Keywords:  Test evaluation; biomarker; clinical accuracy; clinical performance; medical tests; research methods

Mesh：

Substances：

Year:  2019        PMID： 30987429     DOI： 10.1177/0004563219842265

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN： 0004-5632            Impact factor:   2.057


× No keyword cloud information.
  5 in total

1.  Use of Routine Health Datasets to Assess the Appropriateness of Diagnostic Tests in the Follow-Up of Breast Cancer Patients: A Population-Based Study on 3930 Patients.

Authors:  Massimo Gion; Giulia Cardinali; Stefano Guzzinati; Paolo Morandi; Chiara Trevisiol; Aline S C Fabricio; Massimo Rugge; Manuel Zorzi
Journal:  Risk Manag Healthc Policy       Date:  2022-05-19

2.  Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing.

Authors:  Tze Ping Loh; Sarah J Lord; Katy Bell; Mary Kathryn Bohn; Chun Yee Lim; Corey Markus; Hernan Fares Taie; Khosrow Adeli; Giuseppe Lippi; Sverre Sandberg; Andrea Horvath
Journal:  Clin Biochem       Date:  2020-11-20       Impact factor: 3.281

3.  Serum N-glycan profiles differ for various breast cancer subtypes.

Authors:  Gerda C M Vreeker; Kiki M H Vangangelt; Marco R Bladergroen; Simone Nicolardi; Wilma E Mesker; Manfred Wuhrer; Yuri E M van der Burgt; Rob A E M Tollenaar
Journal:  Glycoconj J       Date:  2021-04-20       Impact factor: 2.916

Review 4.  Challenges in Glioblastoma Radiomics and the Path to Clinical Implementation.

Authors:  Philip Martin; Lois Holloway; Peter Metcalfe; Eng-Siew Koh; Caterina Brighi
Journal:  Cancers (Basel)       Date:  2022-08-12       Impact factor: 6.575

Review 5.  Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury.

Authors:  T T van Duijl; D Soonawala; J W de Fijter; L R Ruhaak; C M Cobbaert
Journal:  Clin Proteomics       Date:  2021-02-22       Impact factor: 3.988
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.